2023-01-25 23:50:00

Global Proteomics Partnering Analysis Report 2022: Terms and Agreements for 600+ Deals Entered into by the Worlds...

Logo PR Newswire
PR Newswire

DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Proteomics Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Proteomics Partnering Terms and Agreements 2010 to 2022 report provides an understanding and access to 600+ proteomics partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter proteomics partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors proteomics technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains links to online copies of actual proteomics deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of proteomics dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in proteomics dealmaking since 2010, including details of average headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading proteomics deals since 2010. Deals are listed by headline value, signed by big pharma, most active proteomics dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in proteomics dealmaking with a brief summary followed by a comprehensive listing of proteomics deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive and detailed review of proteomics partnering deals signed and announced since Jan 2010. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of proteomicss partnering deals signed and announced since Jan 2010. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided organized by Proteomics partnering company A-Z, deal type definitions and proteomics partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Report scope

Global Proteomics Partnering Terms and Agreements 2010 to 2022 includes:

  • Trends in proteomics dealmaking in the biopharma industry since 2010
  • Access to headline, upfront, milestone and royalty data
  • Access to over 600 proteomics deal records and contract documents where available
  • The leading proteomics deals by value since 2010
  • Most active proteomics dealmakers since 2010
  • The leading proteomics partnering resources

In Global Proteomics Partnering Terms and Agreements 2010 to 2022, the available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy and technology target

Analyzing actual company deals and agreements allows assessment of the following:

  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What are the precise rights granted or optioned?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in proteomics dealmaking
2.1. Introduction
2.2. Proteomics partnering over the years
2.3. Most active proteomics dealmakers
2.4. Proteomics partnering by deal type
2.5. Proteomics partnering by therapy area
2.6. Deal terms for proteomics partnering
2.6.1 Proteomics partnering headline values
2.6.2 Proteomics deal upfront payments
2.6.3 Proteomics deal milestone payments
2.6.4 Proteomics royalty rates

Chapter 3 - Leading proteomics deals
3.1. Introduction
3.2. Top proteomics deals by value

Chapter 4 - Most active proteomics dealmakers
4.1. Introduction
4.2. Most active proteomics dealmakers
4.3. Most active proteomics partnering company profiles

Chapter 5 - Proteomics contracts dealmaking directory
5.1. Introduction
5.2. Proteomics contracts dealmaking directory

Chapter 6 - Proteomics dealmaking by technology type

Appendices

Appendix 1 - Proteomics deals by company A-Z
Appendix 2 - Proteomics deals by stage of development
Appendix 3 - Proteomics deals by deal type
Appendix 4 - Proteomics deals by therapy area
Appendix 5 - Appendix 6 - Recent report titles from

For more information about this report visit https://www.researchandmarkets.com/r/za6ggg-proteomics?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/global-proteomics-partnering-analysis-report-2022-terms-and-agreements-for-600-deals-entered-into-by-the-worlds-leading-healthcare-companies-301730952.html

SOURCE Research and Markets

Logo PR Newswire
HealthPress Release2023-01-25 18:50:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. A $9.2 Billion...

Logo PR Newswire
HealthPress Release2023-01-25 22:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2031" report has been added to...

Logo PR Newswire
HealthPress Release2023-01-25 10:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Apparel Markets: Business Update, 2022 - Part Three" report from Textiles Intelligence Ltd. has been added...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Car Care Products Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This...

Logo PR Newswire
HealthPress Release2023-01-25 14:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Body Fluid Collection and Diagnostic Market by Sample Type, Product, Application, Technology (Polymerase Chain...

Logo PR Newswire
HealthPress Release2023-01-25 15:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Consumer Genomics Market (2022-2027) by Product and Service, Application, and Geography, Competitive...

Logo PR Newswire
HealthPress Release2023-01-25 01:00:00
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- According to Technavio, the global medical billing outsourcing market size is estimated to grow by USD 11,704.49...

Logo PR Newswire
HealthPress Release2023-01-25 00:00:00
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Global Photoimmunotherapy Market by Therapeutic Area, End-user, and Region: Competition Forecast and Opportunities...

Logo PR Newswire
HealthPress Release2023-01-25 23:00:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Gene Therapy Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
TechnologyPress Release2023-01-25 19:00:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Metaverse: Global Market Size, Trends and Forecast (2022-2027)" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
TechnologyPress Release2023-01-25 21:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "4G Services Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "RegTech Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
HealthPress Release2023-01-25 00:30:00
Surge in demand for analytical testing services for medical devices such as physical testing, biocompatibility testing and sterility testing, from the...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Food Allergy Diagnostics & Therapeutics Market (2022-2027) by Product Type, Source, End-user, and...

Logo PR Newswire
TechnologyPress Release2023-01-25 12:10:00
The partnership would help health-care organizations vertically integrate with Cloud/AI solutions to unify stakeholder experiences across the value chain and...

Logo PR Newswire
DUBLIN, Jan. 25, 2023 /PRNewswire/ --The "Global Carbon Credit Trading Platform Market by Type (Voluntary, Regulated), System Type (Cap and Trade, Baseline...

Logo PR Newswire
HealthPress Release2023-01-25 18:40:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "The Global Market for Wearable Electronic Skin Patches 2023-2033" report has been added to...

Logo PR Newswire
HealthPress Release2023-01-25 21:10:00
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Optometry Equipment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...